Show simple item record

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

dc.contributor.authorPeach, Megan L
dc.contributor.authorBeedie, Shaunna-L
dc.contributor.authorChau, Cindy H.
dc.contributor.authorCollins, Matthew K
dc.contributor.authorMarkolovic, Suzana
dc.contributor.authorLuo, Weiming
dc.contributor.authorTweedie, David
dc.contributor.authorSteinebach, Christian
dc.contributor.authorGreig, Nigel H
dc.contributor.authorGütschow, Michael
dc.contributor.authorVargesson, Neil
dc.contributor.authorNicklaus, Marc C.
dc.contributor.authorFigg, William D
dc.date.accessioned2020-12-03T09:13:00Z
dc.date.available2020-12-03T09:13:00Z
dc.date.issued2020-12-02
dc.identifier.citationPeach , M L , Beedie , S-L , Chau , C H , Collins , M K , Markolovic , S , Luo , W , Tweedie , D , Steinebach , C , Greig , N H , Gütschow , M , Vargesson , N , Nicklaus , M C & Figg , W D 2020 , ' Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs ' , Molecules , vol. 25 , no. 23 , 5683 . https://doi.org/10.3390/molecules25235683en
dc.identifier.issn1420-3049
dc.identifier.otherPURE: 180501418
dc.identifier.otherPURE UUID: fcfdaaf4-3033-49ca-a506-b5d51d1fb10d
dc.identifier.otherScopus: 85097310887
dc.identifier.otherWOS: 000598022600001
dc.identifier.urihttps://hdl.handle.net/2164/15442
dc.descriptionFunding: This research was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (ZIA SC006538); in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E; the Intramural Research Program of the National Institute on Aging, National Institutes of Health; and a Wellcome Trust-NIH PhD Studentship to SB, WDF, and NV (Grant number 098252/Z/12/Z). Acknowledgments: The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.en
dc.format.extent18
dc.language.isoeng
dc.relation.ispartofMoleculesen
dc.rights© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license (http://creativecommons.org/licenses/by/4.0/).en
dc.subjectangiogenesisen
dc.subjectthalidomideen
dc.subjectSARen
dc.subjectcereblonen
dc.subjectdockingen
dc.subjectstructure-activityen
dc.subjectrelationshipsen
dc.subjectstructure–activity relationshipsen
dc.subjectR Medicineen
dc.subjectDrug Discoveryen
dc.subjectAnalytical Chemistryen
dc.subjectChemistry (miscellaneous)en
dc.subjectMolecular Medicineen
dc.subjectPhysical and Theoretical Chemistryen
dc.subjectPharmaceutical Scienceen
dc.subjectOrganic Chemistryen
dc.subjectWellcome Trusten
dc.subject098252/Z/12/Zen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleAntiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cell, Developmental and Cancer Biologyen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3390/molecules25235683
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85097310887&partnerID=8YFLogxKen
dc.identifier.vol25en
dc.identifier.iss23en


Files in this item

Thumbnail
Name:
Peach_et_al_MDPI_Antiangiogeni ...
Size:
4.898Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record